Prion Diseases
Overview of CJD and other prion diseases.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Clinical Guidelines
CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products (EMA)
National
CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products (Revision 2)National
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementiaNational
Health Technical Memorandum 01-01. Part A: Management and decontamination of surgical instruments (medical devices) used in acute careNational
Infection control of CJD, vCJD and other human prion diseases in healthcare and community settings (ACDP TSE Risk Management Subgroup Guidance)National
World Health Organization: WHO infection control guidelines for transmissible spongiform encephalopathies (TSEs)National
World Health Organization: WHO infection control guidelines for transmissible spongiform encephalopathies (TSEs), including prion diseasesNational
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare SettingsLocal
Clinical Testing Guidance for Blood Safety: Prion DiseasesLocal
Disinfection and Sterilization of Prion-Contaminated Medical Instruments (SHEA Guideline)Local
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementiaLocal
Guideline for disinfection and sterilization of prion-contaminated medical instrumentsLocal
Guidelines for Environmental Infection Control in Health-Care FacilitiesLocal
Prion Disease Reporting and Investigation GuidelineLocal
Review of guidelines for prevention of Creutzfeldt–Jakob disease transmission in healthcare settings (ECDC)Local